Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 isolates from Pennsylvania.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
21 Apr 2021
21 Apr 2021
Historique:
pubmed:
29
4
2021
medline:
29
4
2021
entrez:
28
4
2021
Statut:
epublish
Résumé
Rapid whole genome sequencing of SARS-CoV-2 has presented the ability to detect new emerging variants of concern in near real time. Here we report the genome of a virus isolated in Pennsylvania in March 2021 that was identified as lineage B.1.1.7 (VOC-202012/01) that also harbors the E484K spike mutation, which has been shown to promote "escape" from neutralizing antibodies
Identifiants
pubmed: 33907751
doi: 10.1101/2021.04.21.440801
pmc: PMC8077577
pii:
doi:
Types de publication
Preprint
Langues
eng
Commentaires et corrections
Type : UpdateIn
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no competing interests.
Références
Elife. 2020 Oct 28;9:
pubmed: 33112236
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Genome Biol Evol. 2021 Sep 1;13(9):
pubmed: 34432021
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Open Forum Infect Dis. 2020 Nov 13;8(6):ofaa551
pubmed: 34095334
Cell. 2021 Apr 29;184(9):2348-2361.e6
pubmed: 33730597
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
Nature. 2021 May;593(7857):136-141
pubmed: 33706364
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Cell. 2021 Apr 29;184(9):2523
pubmed: 33930298
Nat Med. 2021 Apr;27(4):717-726
pubmed: 33664494
N Engl J Med. 2021 Mar 17;384(15):1468-1470
pubmed: 33730471
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508